A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates

[1]  Christian Fuchsberger,et al.  Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion , 2012, Nature Genetics.

[2]  S. Gabriel,et al.  Analysis of 6,515 exomes reveals a recent origin of most human protein-coding variants , 2012, Nature.

[3]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[4]  Patrick F. Sullivan,et al.  zCall: a rare variant caller for array-based genotyping: Genetics and population analysis , 2012, Bioinform..

[5]  M. Stephens,et al.  Genome-wide Efficient Mixed Model Analysis for Association Studies , 2012, Nature Genetics.

[6]  E. Zeggini.  Next-generation association studies for complex traits , 2011, Nature Genetics.

[7]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[8]  Wei Chen,et al.  Longitudinal Genome-Wide Association of Cardiovascular Disease Risk Factors in the Bogalusa Heart Study , 2010, PLoS genetics.

[9]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[10]  P. Ridker,et al.  Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction: Genomewide Analysis Among 18 245 Initially Healthy Women From the Women’s Genome Health Study , 2009, Circulation. Cardiovascular genetics.

[11]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[12]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[13]  Christian Gieger,et al.  Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts , 2009, Nature Genetics.

[14]  J. O’Connell,et al.  A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection , 2008, Science.

[15]  Pall I. Olason,et al.  Detection of sharing by descent, long-range phasing and haplotype imputation , 2008, Nature Genetics.

[16]  A. Bergman,et al.  Lipoprotein Genotype and Conserved Pathway for Exceptional Longevity in Humans , 2006, PLoS biology.

[17]  A. Nissinen,et al.  Food intake patterns and 25-year mortality from coronary heart disease: Cross-cultural correlations in the Seven Countries Study , 1999, European Journal of Epidemiology.

[18]  N. Wareham,et al.  Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men. , 2003, Biochimica et biophysica acta.

[19]  M. Olivier,et al.  Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. , 2002, Human molecular genetics.

[20]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[21]  Kenneth Lange,et al.  Use of population isolates for mapping complex traits , 2000, Nature Reviews Genetics.

[22]  P. Duchateau,et al.  A novel apolipoprotein C-III variant, apoC-III(Gln38-->Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin. , 1997, Journal of lipid research.

[23]  J. Breslow,et al.  Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. , 1995, The Journal of clinical investigation.

[24]  M. de Lorgeril,et al.  Cretan Mediterranean diet for prevention of coronary heart disease. , 1995, The American journal of clinical nutrition.

[25]  Chun-Fang Xu,et al.  Association between genetic variation at the APO AI‐CIII‐AIV gene cluster and familial combined hyperlipidaemia , 1994, Clinical genetics.

[26]  A. von Eckardstein,et al.  Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient. , 1994, Journal of lipid research.

[27]  J. Breslow,et al.  An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. von Eckardstein,et al.  Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. , 1991, The Journal of clinical investigation.

[29]  T. Ogura,et al.  Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation. , 1987, Journal of lipid research.

[30]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[31]  A. Keys.  CORONARY HEART DISEASE IN SEVEN COUNTRIES , 1971, The Medical journal of Australia.

[32]  S. Bondurant.  Symposium on Research on Acute Myocardial Infarction , 1970 .